Vitrectomized eyes are challenging to implant intraocular lens (IOL) secondarily. Secondary
intraocular lens (IOL) implantation is often required, particularly when there is a preexisting zonular
or capsular weakness or removal of a cataractous lens during a primary vitrectomy procedure. The
present study was planned to evaluate the associate factors that influence the outcome of secondary
IOL implantation in aphakic vitrectomized eyes. It was a prospective longitudinal study. The study was
done in Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh from April 2022- March 2023.
Detailed information was obtained in each cases according to protocol. Complete history was taken
either from patient or accompanying attendants. With proper evaluation patient was diagnosed of
vitrectomized aphakic eyes then patient under to surgery. IOL was given by scleral flaps or clear
corneal incision and it was fixated in different location. After all post-operative visual acuity and other
positive finding will be recorded. Collected data were classified, edited, coded and entered into the
computer for statistical analysis by using SPSS version 23. Out of 42 patients with vitrectomized
aphakic eyes, majority 15(35.7%) patients belonged to age group 41-50 years with the mean age was
39.5±14.7 year. Male to female ratio was 2.2:1. The BCVA ranged from 0.1 to 1.0 after secondary IOL
implantation in vitrectomy. In this study, one eye (2.4%) had final BCVA of 1.0 and 30 eyes (71.4%)
had a BCVA ranging from 0.3 to 1.0 at the 3rd follow-up (3rd month). The other 11 eyes (26.2%)
achieved final BCVA from 0.1 to 0.3. The mean IOP was significantly increased in different follow up
than baseline (p<0.05). The mean interval between secondary IOL implantation was 2.7±1.5 months.
Postoperative complications after secondary IOL implantation included mild anterior chamber
exudates in 5 eyes (11.9%), temporary IOP elevation in 6 eyes (14.3%), decentered IOL in 3 eyes
(7.1%), exposed suture in 3 eyes (7.1%) and corneal oedema in 5 eyes (11.9%). Our results indicate
that secondary foldable IOL implantation is a safe and effective option, with few reported
complications in eyes which underwent vitrectomy for ocular injury. A small proportion reported mild
intraocular pressure elevation, but IOP remained within the normal range. Thus, currently practiced
methods of secondary IOL implantation covered by the current study appear safe and effective.